InnovAge Holding Corp. (INNV)
USD 2.91
(5.43%)
USD 2.91
(5.43%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 763.85 Million USD | 11.01% |
| 2023 | 688.08 Million USD | -1.51% |
| 2022 | 698.64 Million USD | 9.54% |
| 2021 | 637.8 Million USD | 12.45% |
| 2020 | 567.19 Million USD | 21.81% |
| 2019 | 465.63 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 FY | 763.85 Million USD | 11.01% |
| 2024 Q2 | 188.89 Million USD | 3.51% |
| 2024 Q4 | 199.4 Million USD | 3.28% |
| 2024 Q1 | 182.48 Million USD | 3.17% |
| 2024 Q3 | 193.07 Million USD | 2.21% |
| 2023 Q3 | 172.53 Million USD | 3.04% |
| 2023 FY | 688.08 Million USD | -1.51% |
| 2023 Q4 | 176.87 Million USD | 2.51% |
| 2023 Q2 | 167.45 Million USD | -2.2% |
| 2023 Q1 | 171.21 Million USD | -0.95% |
| 2022 Q3 | 177.35 Million USD | 1.15% |
| 2022 Q4 | 172.86 Million USD | -2.54% |
| 2022 Q1 | 173.07 Million USD | 0.85% |
| 2022 Q2 | 175.35 Million USD | 1.32% |
| 2022 FY | 698.64 Million USD | 9.54% |
| 2021 Q4 | 171.61 Million USD | 9.79% |
| 2021 FY | 637.8 Million USD | 12.45% |
| 2021 Q2 | 157.31 Million USD | 3.11% |
| 2021 Q3 | 156.3 Million USD | -0.64% |
| 2021 Q1 | 152.56 Million USD | 0.05% |
| 2020 Q3 | 144.77 Million USD | 0.0% |
| 2020 Q4 | 152.49 Million USD | 5.33% |
| 2020 FY | 567.19 Million USD | 21.81% |
| 2019 FY | 465.63 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 2.92 Billion USD | 73.919% |
| Addus HomeCare Corporation | 1.05 Billion USD | 27.846% |
| AirSculpt Technologies, Inc. | 195.91 Million USD | -289.887% |
| Amedisys, Inc. | 2.23 Billion USD | 65.844% |
| American Oncology Network, Inc. | 1.27 Billion USD | 40.286% |
| Astrana Health, Inc. | 1.38 Billion USD | 44.914% |
| Aveanna Healthcare Holdings Inc. | 1.89 Billion USD | 59.695% |
| IMAC Holdings, Inc. | 5.19 Million USD | -14597.999% |
| biote Corp. | 185.36 Million USD | -312.093% |
| Cryo-Cell International, Inc. | 31.34 Million USD | -2337.029% |
| Cross Country Healthcare, Inc. | 2.01 Billion USD | 62.18% |
| COMPASS Pathways plc | - USD | -Infinity% |
| DocGo Inc. | 624.28 Million USD | -22.356% |
| The Ensign Group, Inc. | 3.72 Billion USD | 79.518% |
| Healthcare Services Group, Inc. | 1.67 Billion USD | 54.298% |
| Assure Holdings Corp. | 255 Thousand USD | -299450.98% |
| The Joint Corp. | 117.69 Million USD | -549.005% |
| LifeStance Health Group, Inc. | 1.05 Billion USD | 27.642% |
| Mobile-health Network Solutions Class A Ordinary Shares | 10.35 Million USD | -7274.173% |
| ModivCare Inc. | 2.75 Billion USD | 72.235% |
| NewGenIvf Group Limited | 5.13 Million USD | -14772.123% |
| Novo Integrated Sciences, Inc. | 12.57 Million USD | -5975.834% |
| Option Care Health, Inc. | 4.3 Billion USD | 82.246% |
| P3 Health Partners Inc. | 1.26 Billion USD | 39.682% |
| P3 Health Partners Inc. | 1.26 Billion USD | 39.682% |
| The Pennant Group, Inc. | 544.89 Million USD | -40.185% |
| Surgery Partners, Inc. | 2.74 Billion USD | 72.156% |
| Syra Health Corp. Class A Common Stock | 5.51 Million USD | -13750.137% |
| Talkspace, Inc. | 150.04 Million USD | -409.084% |
| Talkspace, Inc. | 150.04 Million USD | -409.084% |
| The Oncology Institute, Inc. | 324.23 Million USD | -135.584% |
| The Oncology Institute, Inc. | 324.23 Million USD | -135.584% |